© 2017 by RareFundingTeam

Admin
Aug 25, 2017

WordPress Template for MLD Foundation Site

0 comments

Edited: Sep 3, 2017

 

 

The MLD Foundation is a 501(c)(3) non-profit US tax-exempt organization. We were formed in May 2001 to serve families throughout the world affected by metachromatic leukodystrophy (MLD), a terminal genetic disease.

 

We C.A.R.E.™ ... Compassion for families, increasing Awareness, influencing & funding Research, and promoting Education for metachromatic leukodystrophy, a very rare terminal genetic neuro-metabolic disease where over half the cases affect infants. We are a small two person unsalaried organization with a global reach. We are active in MLD projects as well as rare disease policy and newborn screening.

 

Primary Contact Name: Dean Suhr

 

Contact Person Email: deansuhr@MLDfoundation.org

 

# of Hours: 20

 

When do you need the project to begin? : 09-01-2017

 

Guidestar Entry (USA only): https://www.guidestar.org/profile/93-1320953

Commenting is off for this post.
New Posts
  • Admin
    Jan 22, 2018

    Succinic Semialdehyde Dehydrogenase Deficiency or SSADH is an extremely rare neurological disorder which is only shared by around 400 people world-wide, there is no known treatment. Symptoms include: Delayed gross motor development Delayed mental development Delayed fine motor skill development Delayed speech and language development Low Muscle Tone Information on SSADH Organization: The organization has 5 Major Goals in mind: 1. Build a Network of patients, therapist, medical doctors and scientific researchers. 2. Raise money to fund research and treatments 3. Raise awareness in public for the ultra-rare enzymatic disorder. 4. Foster Research in diagnosis and therapeutic Treatment for SSADH. There are two Projects ( Note, projects 1 & 2 can be different individuals. PROJECT #1 Move the site from its current host to a new, host which facilitates WordPress, site to be determined PROJECT #2 Upgrade the primary site both visually and textually in WordPress format. The site must have the following functionality: A. Process donations to include the following: i. High level of web based security ii. Process credit card transactions, both US and Non-US iii. Process from the site to the bank account of the SSADH organization iv. Issue tax free receipts B. Collect and store contact information from visitors and donors on the site C. Using the visitor and donor data send emails/newsletters D. The SSADH staff should be able to create emails and newsletters E. Good to have: Ability to integrate database with golf/fundraising data base F. Connect golf/fundraising site to primary site Primary Contact Name: Carolyn Hoffman Contact Person Email: choffmanwi@aol.com
  • Admin
    Oct 26, 2017

    AHDS-MCT8 Patient Organization is the first patient organization to represent patients affected by Allan-Herndon-Dydley syndrome . The small AHDS community, with the invaluable support of the Sherman Foundation, managed to create this organization aimed at rising interest within the research community in the hope of finding a cure, offering support to patients and their families and lat but not least, rising awareness about this syndrome. AHDS is an extremely rare genetic syndrome that only affects boys. It has no cure and no treatment even though it has been originally described for the first time in 1944. It involves severe intellectual and motor delay. Type of Project/Purpose: Press release to announce AHDS-MCT8 as the first patient organization for people affected by Allan-Herndon-Dudley syndrome. Primary Contact Name: Veronica Popa Contact Person Email: Forthcoming: ahds.mct8@gmail.com # of Hours: 4
  • Admin
    Aug 25, 2017

    Patients need a platform to exchange ideas with each other - we do not consider Facebook to be such a platform. Thus, we would like to provide a Password-protected chat-site on our WordPress account. Patients should Login with their email+password, the thread of discussion should be only disclosed to patients and our scientific board. Succinic Semialdehyde Dehydrogenase Deficiency or SSADH is an extremely rare neurological disorder which is only shared by around 400 people world- wide, there is no known treatment: Symptoms include: Delayed gross motor development Delayed mental development Delayed fine motor skill development Delayed speech and language development Low Muscle Tone Our association is the only one in Germany that provides Information on SSADH. Patients are founders of SSADH-Deficit e.V. and have 3 Major Goals in mind: 1. Built a Network of patients, therapist, medical doctors and scientific Researchers. 2. Raise awareness in public for the ultra-rare enzymatic disorder. 3. Foster Research in diagnosis and therapeutic Treatment for SSADH. Primary Contact Name: Claudio Cinquemani Contact Person Email: cinquemani@gmx.de # of Hours: 3 - 10